The Pediatric Rehabilitation Department, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Biomed Res Int. 2018 Jun 13;2018:2197163. doi: 10.1155/2018/2197163. eCollection 2018.
The Alberta Infant Motor Scale (AIMS) is widely used to screen for delays in motor development in high-risk infants, but its reliability and validity in Chinese infants have not been investigated. To examine the reliability and concurrent validity of AIMS in high-risk infants aged 0-9 months in China, this single-center study enrolled 50 high-risk infants aged 0-9 months (range, 0.17-9.27; average, 4.14±2.02), who were divided into two groups: 0-3 months (n=23) and 4-9 months (n=27). A physical therapist evaluated the infants with AIMS, with each evaluation video-recorded. To examine interrater reliability, two other evaluators calculated AIMS scores by observing the videos. To measure intrarater reliability, the two evaluators rescored AIMS after >1 month, using the videos. Concurrent validity was assessed by comparing results between AIMS and the Peabody Developmental Motor Scale-2 (PDMS-2). For all age groups analyzed (0-3, 4-9, and 0-9 months), intraclass correlation coefficients (ICCs) for AIMS total score were high for both intrarater comparisons (0.811-0.995) and interrater comparisons (0.982-0.997). AIMS total scores were well correlated with all PDMS-2 subtest scores (ICC=0.751-0.977 for reflexes, stationary, locomotion, grasping, and visual-motor integration subsets). However, the fifth percentile of AIMS total score was only moderately correlated with the gross motor quotient, fine motor quotient, and total motor quotient subtests of PDMS-2 (kappa=0.580, 0.601, and 0.724, respectively). AIMS has acceptable reliability and concurrent validity for screening of motor developmental delay in high-risk infants in China.
阿尔伯塔婴儿运动量表(AIMS)广泛用于筛查高危婴儿的运动发育迟缓,但尚未研究其在中国婴儿中的可靠性和有效性。为了研究 AIMS 在 0-9 个月高危婴儿中的可靠性和同时效度,本单中心研究纳入了 50 名 0-9 个月(0.17-9.27 岁;平均 4.14±2.02 岁)的高危婴儿,分为 0-3 个月(n=23)和 4-9 个月(n=27)两组。物理治疗师使用 AIMS 对婴儿进行评估,每次评估均录像。为了检验评分者间信度,另外两名评估者通过观察录像计算 AIMS 评分。为了测量评分者内信度,两名评估者在>1 个月后使用录像重新评分 AIMS。同时效度通过 AIMS 与 Peabody 发育运动量表-2(PDMS-2)的结果比较来评估。对于分析的所有年龄组(0-3、4-9 和 0-9 个月),AIMS 总分的组内相关系数(ICC)在评分者内比较(0.811-0.995)和评分者间比较(0.982-0.997)中均较高。AIMS 总分与 PDMS-2 的所有子测试得分均高度相关(反射、站立、运动、抓握和视觉运动整合子测试的 ICC=0.751-0.977)。然而,AIMS 总分的第 5 个百分位数与 PDMS-2 的粗大运动商数、精细运动商数和总运动商数子测试仅中度相关(kappa=0.580、0.601 和 0.724)。AIMS 在中国高危婴儿中筛查运动发育迟缓具有可接受的可靠性和同时效度。